The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans-Reference-Cited by-同舟云学术

The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans

Published:2008-09-02 Issue:9 Volume:118 Page:3025-3037
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Toyama Kazuyoshi,Wulff Heike,Chandy K. George,Azam Philippe,Raman Girija,Saito Takashi,Fujiwara Yoshimasa,Mattson David L.,Das Satarupa,Melvin James E.,Pratt Phillip F.,Hatoum Ossama A.,Gutterman David D.,Harder David R.,Miura Hiroto

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference60 articles.

1. Inflammation in atherosclerosis

2. Pathogen-Sensing Plasmacytoid Dendritic Cells Stimulate Cytotoxic T-Cell Function in the Atherosclerotic Plaque Through Interferon-α

3. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

4. Molecular Cloning and Characterization of the Intermediate-Conductance Ca 2+ -Activated K + Channel in Vascular Smooth Muscle

5. Role Of Augmented Expression Of Intermediate-Conductance CA2+-Activated K+ Channels In Postischaemic Heart

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redox Regulation of K⁺ Channel: Role of Thioredoxin;Antioxidants & Redox Signaling;2024-08-28

2. KCa3.1 promotes the migration of macrophages from epicardial adipose tissue to induce vulnerability to atrial fibrillation during rapid pacing;Canadian Journal of Cardiology;2024-08

3. Nitric oxide, endothelium‐derived hyperpolarizing factor, and smooth muscle‐dependent mechanisms contribute to magnesium‐dependent vascular relaxation in mouse arteries;Acta Physiologica;2024-01-23

4. Potassium channels as novel molecular targets in hepatocellular carcinoma (Review);Oncology Reports;2023-08-24

5. Elabela relaxes rat pulmonary artery and trachea via BKCa, KV, and KATP channels;Prostaglandins & Other Lipid Mediators;2023-08